CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Shineco, Inc.  (TYHT)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Shineco's Leverage Ratio

TYHT's quarterly Leverage Ratio and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:                        

TYHT Leverage Ratio (Mar 31 2017)
III. Quarter
(Sep 30 2016)
I. Quarter



Y / Y Equity Change - - - - -
Y / Y Total Liabilities Change - - - - -
Leverage Ratio MRQ 0.11 0.15 - - -
Overall Ranking # 303 # 0 # # #
Seq. Equity Change 5.37 % - - - -
Seq. Total Liabilities Change -24.74 % - - - -



Leverage Ratio third quarter 2017 Comment
Due to repayements of liabilities of -24.74% Shineco improved Leverage Ratio in third quarter 2017 to 0.11, a new company low.

Within Major Pharmaceutical Preparations industry in the third quarter 2017, 54 other companies have achieved lower Leverage Ratio than Shineco. While Leverage Ratio total ranking has deteriorated compare to previous quarter from to 302.

Explain Leverage Ratio?
Who are TYHT Customers?
Leverage Ratio third quarter 2017 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 55
Healthcare Sector # 112
Overall Market # 302


Leverage Ratio Statistics
High Average Low
0.15 0.13 0.11
(Sep 30 2016)   (Mar 31 2017)


You need to upgrade your Flash Player


Financial Statements
Shineco's Equity $ 60 Millions Visit TYHT's Balance sheet
Shineco's Total Liabilities $ 6 Millions Visit TYHT's Balance sheet
Source of TYHT's Sales Visit TYHT's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingMar 31 2017, within Major Pharmaceutical Preparations Industry Leverage RatioMar 31 2017 MRQ Total LiabilitiesMar 31 2017 MRQ Equity
Puma Biotechnology, Inc.  0.29 $ 49.232  Millions$ 167.392  Millions
Cempra, Inc.  0.29 $ 47.686  Millions$ 162.812  Millions
Albireo Pharma, Inc.  0.29 $ 9.095  Millions$ 31.207  Millions
Threshold Pharmaceuticals Inc  0.29 $ 4.448  Millions$ 15.327  Millions
Epizyme, Inc.  0.28 $ 49.385  Millions$ 174.521  Millions
Athersys, Inc  0.28 $ 8.133  Millions$ 29.216  Millions
Antriabio, Inc.  0.28 $ 2.335  Millions$ 8.460  Millions
Rxi Pharmaceuticals Corp  0.27 $ 2.265  Millions$ 8.247  Millions
Pfenex Inc.  0.27 $ 19.441  Millions$ 71.119  Millions
Minerva Neurosciences, Inc.  0.27 $ 29.020  Millions$ 106.286  Millions
Cumberland Pharmaceuticals Inc  0.27 $ 19.503  Millions$ 72.212  Millions
Verastem, Inc.  0.26 $ 15.777  Millions$ 60.472  Millions
Insys Therapeutics, Inc.  0.26 $ 69.810  Millions$ 267.786  Millions
Nabriva Therapeutics Plc  0.26 $ 16.227  Millions$ 62.721  Millions
Moleculin Biotech, Inc.  0.26 $ 4.175  Millions$ 16.142  Millions
Opko Health, Inc.  0.23 $ 493.812  Millions$ 2,106.970  Millions
Titan Pharmaceuticals Inc  0.23 $ 2.467  Millions$ 10.607  Millions
Flexion Therapeutics Inc  0.23 $ 38.194  Millions$ 166.099  Millions
Kura Oncology, Inc.  0.22 $ 11.250  Millions$ 50.241  Millions
Collegium Pharmaceutical, Inc  0.22 $ 25.481  Millions$ 114.367  Millions
Clearside Biomedical, Inc.  0.22 $ 14.795  Millions$ 67.163  Millions
Rigel Pharmaceuticals Inc  0.21 $ 17.245  Millions$ 84.081  Millions
Chembio Diagnostics, Inc.  0.20 $ 3.515  Millions$ 17.373  Millions
Sarepta Therapeutics, Inc.  0.19 $ 82.391  Millions$ 429.142  Millions
Neothetics, Inc.  0.19 $ 1.698  Millions$ 9.035  Millions
Gemphire Therapeutics Inc.  0.18 $ 4.545  Millions$ 25.297  Millions
Macrogenics Inc  0.18 $ 41.594  Millions$ 234.638  Millions
Immune Design Corp.  0.17 $ 14.816  Millions$ 85.066  Millions
Madrigal Pharmaceuticals, Inc.  0.17 $ 5.906  Millions$ 34.451  Millions
Glycomimetics Inc  0.17 $ 5.288  Millions$ 31.886  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
CPRY's Profile
Stock Price
CPRY's Financials
CPRY's Expectations
Business Description
Fundamentals
Charts & Quotes
CPRY's News
Suppliers
CPRY's Competitors
Customers & Markets
Economic Indicators
CPRY's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com